Unpacking the interests of R&D teams

Last month we set in motion the first in a series of tests to figure out the best way to present to you the R&D interests of companies using the platform. This month, we're shining a light on a specific sector - medical devices and healthcare technologies - to provide you with an insight into what R&D teams in this space are currently looking for.

If you're aware of any technologies or active projects at your institutes that are aligned to the interests below, you can upload the summary article to the platform through your institute's dashboard, or you can let our team know if you already have something online.


- Alex, IN-PART's Communications Manager

Sector breakdown:
Medical devices & healthcare technologies

Teams at eight of the top ten global R&D-spending medical device companies are using IN-PART to search for new technologies and academic partners, including Medtronic, Boston Scientific, BD, Thermo Fisher and Stryker

Companies in this sector have recently shared with us a particular interest in:
  • Prototyped point-of-care diagnostic system
  • The interface between devices, sensors and the body
  • Advances in robotics to improve surgical procedures
  • Capacitive micromachined ultrasonic transducers
  • Activity-based probes to monitor enzymatic activity

Does your institute have any technologies or active projects in these areas?
 
  
New case study:
University of Nottingham: New industry collaboration to test a novel method of detecting low-frequency cancer mutations

Through a match on IN-PART, the University of Nottingham has entered a collaboration with a UK-based life sciences company to test a new cancer-detection technology developed by scientists at the university.

 



Twitter
LinkedIn
Website


Dashboard | Platform | Account | Blog | Legal Policies

IN-PART Publishing Ltd., Parkhead House, Carver Street, Sheffield, S1 4FS

-

This is the monthly bulletin for IN-PART's academic community. If you no longer want to receive the bulletin you can 
change your email preferences here, or if you want to stop hearing from us altogether you can unsubscribe from all of our communications.